CCR2-targeting pepducins reduce T cell-nociceptor interaction driving bone cancer pain

Midavaine E, Brouillette RR, Theberge E, Mona CE, Kashem SW, Cote J, Zeugin V, Besserer-Offroy E, Longpre JM, Marsault E, Sarret P. CCR2-targeting pepducins reduce T cell-nociceptor interaction driving bone cancer pain. bioRxiv. 2023; 15(9):556569.

2023
https://researcherprofiles.org/profile/430211174

Midavaine E, Brouillette RR, Theberge E, Mona CE, Kashem SW, Cote J, Zeugin V, Besserer-Offroy E, Longpre JM, Marsault E, Sarret P